← Back to headlines
Repligen Projects 2026 Revenue and EPS Amid BioLife Deal
Repligen projects 2026 revenue between $813M-$834M and raised EPS to $2.03-$2.09, following its BioLife deal.
28 Jul, 17:24 — 28 Jul, 17:24
Sources
Showing 1 of 1 sources
Related Stories
Explosive Attacks Decline in Netherlands After Years of Increase
just now
Five Bosnian Mountaineers Die on Mount Elbrus, Day of Mourning Declared
just now
LPA Brings Rains and Class Suspensions Across Philippines on July 29
just now
Game Fowl Breeder and Relative Killed by Fake Delivery Rider in Bataan
just now